NASDAQ · Diagnostics & Research

Natera Inc (NTRA)

$273.40 -5.70%
29 Oversold Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$270.09+1.23%

Company profile

Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.

SectorHealthcare
IndustryDiagnostics & Research
Market cap$46.38B
P/E ratioNone
EPS$-1.12
Beta1.515
Dividend yield0.00%
52-week high$437.41
52-week low$181.00

Similar stocks in Diagnostics & Research

30 days of PRO Unlimited free, no card

RSI alerts for NTRA

An email when NTRA closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 3:31 AM EST